BridgeMD
New treatment option for Tobacco Use Disorder
Official title Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation
ClinicalTrials.gov ID: NCT05766553
What this study is testing
- What it's testing
- Investigators seek to propose a non-drug therapeutic alternative, namely a mindfulness meditation protocol based on virtual reality training in order to induce progressive modifications of various indicators of craving. The study hypothesis is that the practice of mindfulness meditation in a virtual reality environment reduces the craving induced by cues and stress and therefore ultimately smoking relapse.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Any patient consuming 10 to 40 cigarettes per day
- Woman or man aged 18 to 75 inclusive
- Substance use disorder according to the DSM5 classification
- Benefit from social security or benefit from it through a third party in accordance with French law on research involving the human person
- Having signed the informed consent form after having received written information.
You likely can't join if
- Disabling cognitive disorders
- Patient under 18 or over 75 years old.
- Patient with a psychological disorder or a psychiatric pathology requiring specialized follow-up
- Patient with addiction to another product.
- Cardiological pathologies that could compromise the participation of patients, detected by an ECG (only for patients who will be assigned by chance...
- Advanced pulmonary, renal, and hepatic diseases, or any unstable and serious medical conditions that could compromise the patient's participation in...
See the full eligibility criteria
- Any patient consuming 10 to 40 cigarettes per day
- Woman or man aged 18 to 75 inclusive
- Substance use disorder according to the DSM5 classification
- Benefit from social security or benefit from it through a third party in accordance with French law on research involving the human person
- Having signed the informed consent form after having received written information.
- Disabling cognitive disorders
- Patient under 18 or over 75 years old.
- Patient with a psychological disorder or a psychiatric pathology requiring specialized follow-up
- Patient with addiction to another product.
- Cardiological pathologies that could compromise the participation of patients, detected by an ECG (only for patients who will be assigned by chance in the experimental group).
- Advanced pulmonary, renal, and hepatic diseases, or any unstable and serious medical conditions that could compromise the patient's participation in the study, subject to the judgment of the doctor
- Pregnant or breastfeeding woman
- Simultaneous participation in another trial
- Employee of the investigator or of the clinical trial site
- Patients protected by law
- Patients who do not speak the French language
- People not covered by state health insurance
- Patients who in the opinion of the investigator are unable to complete the questionnaires
- Patient claustrophobic or anxious about using the cabin
- Patient allergic to a molecule present in nicotine substitutes
The study team makes the final eligibility decision.
Where it's taking place
- Iteuil, France
- Poitiers, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Iteuil, France; Poitiers, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.